1284
THE INFLUENCE OF BODY WEIGHT ON GASTROINTESTINAL (GI) GAS PRODUCTION
Date
May 21, 2024
Introduction: Body weight influences the GI response to meals. Studies have demonstrated post-prandial GI symptoms and dysfunction at the extremes of the BMI scale. More specifically, underweight individuals (BMI < 18.5) often report post-prandial bloating, nausea, and fullness as a result of delayed gastric emptying, as well as prolonged oro-cecal transit time (OCTT). Conversely, individuals with obesity (BMI > 30) may experience impaired satiety and fullness cues. Previous studies had linked higher BMI with elevated methane (CH4) on conventional fasting breath tests. In this real-world study, post-prandial breath hydrogen (H2) and CH4 were measured to investigate the influence of body weight on GI motility and activity of the gut microbiome.
Methods: We studied 3,809 individuals with varying BMI (< 18.5, 18.5-25, 25-30, and 30+) and self-reported GI and non-GI symptoms (bloating, flatulence, abdominal pain, and fatigue). Post-prandial breath H2 and CH4 levels and symptoms were measured from an app-connected, personalized H2 and CH4 device (FoodMarble, Ireland) daily for 1 week while consuming their habitual diet. To assess the association between the diurnal pattern of post-prandial breath gases (H2 and CH4), and BMI, linear regression was applied.
Results: Average age was 44.2 ± 13 years, average BMI was 24.1 ± 5.6, with 35% male and 65% female. By BMI category, 255 (7%) had BMI < 18.5, 2101 (55%) had BMI of 18.5-25, 977 (26%) had BMI of 25-30, and 476 (12%) had BMI of 30+. The top 4 GI and non-GI symptoms at baseline (median, IQR) measured on a scale of 0-10 were bloating (4.4, 3.5-5.6), flatulence (2.9, 0.7-4.5), abdominal pain (1.97, 0.5-3.7) and fatigue (2.44, 0.7-4.5). Those with a higher BMI (25-30 and 30+) on average produced more breath H2 in comparison to those with a normal (18.5-25) or low BMI (< 18.5) (Figure 1). However, the opposite relationship was observed for average CH4 levels over the day, whereby those with a lower BMI (< 18.5) had elevated levels of CH4 and those with the highest BMI produced lower average CH4. More specifically, there was a negative association between BMI and CH4, averaged by the individual (r = -0.99, p-value = 0.01), and a positive association between BMI and H2, averaged by the individual (r = 0.98, p-value = 0.02) in symptomatic individuals.
Conclusions: Recent studies have shown that post-prandial breath H2 is influenced by short-term dietary changes. Here we show that BMI is positively correlated with post-prandial H2 production (r = 0.98, p-value = 0.02), perhaps driven by substrate availability for bacterial fermentation, and post-prandial CH4 production was negatively associated with BMI (r = -0.99, p-value = 0.01). Measuring these gases in real time after meal consumption—as opposed to the fasting state—may offer clinical benefits in monitoring interventions relating to BMI-associated dysmotility.
Methods: We studied 3,809 individuals with varying BMI (< 18.5, 18.5-25, 25-30, and 30+) and self-reported GI and non-GI symptoms (bloating, flatulence, abdominal pain, and fatigue). Post-prandial breath H2 and CH4 levels and symptoms were measured from an app-connected, personalized H2 and CH4 device (FoodMarble, Ireland) daily for 1 week while consuming their habitual diet. To assess the association between the diurnal pattern of post-prandial breath gases (H2 and CH4), and BMI, linear regression was applied.
Results: Average age was 44.2 ± 13 years, average BMI was 24.1 ± 5.6, with 35% male and 65% female. By BMI category, 255 (7%) had BMI < 18.5, 2101 (55%) had BMI of 18.5-25, 977 (26%) had BMI of 25-30, and 476 (12%) had BMI of 30+. The top 4 GI and non-GI symptoms at baseline (median, IQR) measured on a scale of 0-10 were bloating (4.4, 3.5-5.6), flatulence (2.9, 0.7-4.5), abdominal pain (1.97, 0.5-3.7) and fatigue (2.44, 0.7-4.5). Those with a higher BMI (25-30 and 30+) on average produced more breath H2 in comparison to those with a normal (18.5-25) or low BMI (< 18.5) (Figure 1). However, the opposite relationship was observed for average CH4 levels over the day, whereby those with a lower BMI (< 18.5) had elevated levels of CH4 and those with the highest BMI produced lower average CH4. More specifically, there was a negative association between BMI and CH4, averaged by the individual (r = -0.99, p-value = 0.01), and a positive association between BMI and H2, averaged by the individual (r = 0.98, p-value = 0.02) in symptomatic individuals.
Conclusions: Recent studies have shown that post-prandial breath H2 is influenced by short-term dietary changes. Here we show that BMI is positively correlated with post-prandial H2 production (r = 0.98, p-value = 0.02), perhaps driven by substrate availability for bacterial fermentation, and post-prandial CH4 production was negatively associated with BMI (r = -0.99, p-value = 0.01). Measuring these gases in real time after meal consumption—as opposed to the fasting state—may offer clinical benefits in monitoring interventions relating to BMI-associated dysmotility.
Average Hourly Breath Hydrogen (H2) and Breath Methane (CH4) in symptomatic individuals (n=3,809) with varying BMI: (< 18.5) n=255, (18.5-25) n=2101, (25-30) n=977 and (> 30) n=476.
FoodMarble Breath Test Device and Associated Smartphone App
Presenter
Massachusetts General Hospital
Tracks
Related Products
DOES GENDER AFFECT THE SEVERITY OF SYMPTOMS, QUALITY OF LIFE AND PSYCHOLOGICAL TRAITS IN PATIENTS WITH FECAL INCONTINENCE
BACKGROUND: Fecal incontinence (FI) significantly affects patient’s quality of life and leads to psychosocial distress…
CLOSTRIDIOIDES DIFFICILE INFECTION INDUCES A PRO-STEATOTIC AND PRO-INFLAMMATORY METABOLIC STATE IN LIVER
BACKGROUND: Recent studies suggest links between _Clostridioides difficile_ infection (CDI) and liver disorders, with non-alcoholic fatty liver disease (NAFLD) increasing CDI risk and CDI exacerbating the progression and prognosis of liver cirrhosis. Moreover, gut dysbiosis, often leading to _C…
Constipation and Other Functional Colonic Syndromes
Novel Clinical Therapy and Diagnostics for Constipation
